Lack of specificity of endoglin expression for tumor blood vessels

International Journal of Cancer

Volumn 94, Issue 4, 2001, Pages 579-585

  Balza, Enrica ^a   Castellani, Patrizia ^a   Zijlstra, Andries ^a   Neri, Dario ^b   Zardi, Luciano ^a   Siri, Annalisa ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b ETH ZURICH   (Switzerland)

Author keywords

Endoglin; Normal vessels; Stroma; Tumor vessels

Indexed keywords

ENDOGLIN; MONOCLONAL ANTIBODY;

AMINO TERMINAL SEQUENCE; ANTIGEN PURIFICATION; ARTICLE; BREAST CARCINOMA; CHORIOCARCINOMA; ENDOTHELIUM CELL; FIBROSARCOMA; GLIOBLASTOMA; HUMAN; HUMAN CELL; MOLECULAR WEIGHT; MYELOID LEUKEMIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHABDOMYOSARCOMA; TUMOR VASCULARIZATION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; BLOOD VESSELS; BLOTTING, WESTERN; BRAIN; CELL LINE, TRANSFORMED; ENDOTHELIUM, VASCULAR; FLOW CYTOMETRY; GLIOBLASTOMA; HUMANS; IMMUNOGLOBULIN G; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED BALB C; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; RECEPTORS, CELL SURFACE; TISSUE DISTRIBUTION; TUMOR CELLS, CULTURED; UMBILICAL VEINS; UP-REGULATION; VASCULAR CELL ADHESION MOLECULE-1;

EID: 0035889654     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.1505     Document Type: Article

References (44)

1. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
2. Angiogenesis inhibition: A review
3. Clinical application of research on angiogenesis
4. Antibody-directed targeting of the vasculature of solid tumors
5. Identification of human endothelial cell antigen with monoclonal antibody 44G4 produced against a pre-B leukemic cell line
6. Expression of endoglin mRNA and protein in human vascular smooth muscle cells
7. Regulated expression on human macrophages of endoglin, an Arg-Gly-Asp-containing surface antigen
8. Endoglin (CD 105) expression in human lymphoid organs and placenta
9. Characterization of TGF-betal binding proteins in human bone marrow stromal cells
10. Endoglin is expressed on a subpopulation of immature erythroid cells or normal bone marrow
11. Distinct human leukemia-associated cell surface glycoprotein GP160 defined by monoclonal antibody SN6
12. Distribution of endoglin in early human development reveals high levels on endocardial cushion tissue mesenchyme during valve formation
13. Endoglin, an ancillary TGF-beta receptor, is required for extraembryonic angiogenesis and plays a key role in heart development
14. Molecular characterization and in situ localization of murine endoglin reveal that it is a transforming growth factor-beta binding protein of endothelial and stromal cells
15. Characterization of endoglin on mouse uterine stromal cells
16. The monoclonal antibody SH-2, raised against human mesenchymal stem cells, recognizes an epitope on endoglin (CD105)
17. Primary structure of endoglin, an RGD-containing glycoprotein of human endothelial cells
18. Identification and expression of two forms of the human transforming growth factor-beta-binding protein endoglin with distinct cytoplasmic regions
19. Up-regulation of endoglin on vascular endothelial cells in human solid tumors: Implications for diagnosis and therapy
20. A monoclonal antibody detects heterogeneity in vascular endothelium of tumors and normal tissues
21. Characteristics and possible function of endoglin, a TGF-beta binding protein
22. Endoglin forms a heteromeric complex with the signaling receptors for transforming growth factor-beta
23. Endoglin modulates cellular responses to TGF-beta 1
24. Endoglin regulates trophoblast differentiation along the invasive pathway in human placental villous explants
25. Endoglin is an accessory protein that interacts with the signalling receptor complex of multiple members of the transforming growth factor-beta superfamily
26. Endoglin overexpression modulates cellular morphology, migration and adhesion of mouse fibroblasts
27. Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1
28. Mapping epitopes to distinct regions of the extracellular domain of endoglin using bacterially expressed recombinant fragments
29. Induction of lasting complete regression of preformed distinct solid tumours by targeting the tumour vasculature using two new anti-endoglin monoclonal antibodies
30. Antiangiogenic radioimmuno-therapy of human solid tumors in SCID mice using (125)I-labeled anti-endoglin monoclonal antibodies
31. Imaging of tumour neovasculature by targeting the TGF-beta binding receptor endoglin
32. Endoglin is a suitable target for efficient imaging of solid tumors: In vivo evidence in a canine mammary carcinoma model
33. Breast carcinoma vascular density determined using CD105 antibody correlates with tumor prognosis
34. Generation of human umbilical vein endothelial cell lines which maintain their differentiated phenotype
35. Cloning of choriocarcinoma cells shows that invasion correlates with expression and activation of gelatinase-A
36. Somatic cell hybrids producing antibodies specific to human fibronectin
37. Phage antibodies with pan-species recognition of the oncofetal angiogenesis marker fibronectin ED-B domain
38. Targeting by affinity-matured recombinant antibody fragments of an angiogenesis associated fibronectin isoform
39. The fibronectin isoform containing the ED-B oncofetal domain: A marker of angiogenesis
40. A tumour-associated fibronectin isoform generated by alternative splicing of messenger RNA precursors
41. Identification of distinct epitopes of endoglin, an RGD-containing glycoprotein of endothelial cells, leukemic cells and syncytiotrophoblasts
42. Analysis of endoglin expression in normal brain tissue and in cerebral arteriovenous malformations
43. Immunocytochemical detection of endoglin is indicative of angiogenesis in malignant melanoma
44. Long-lasting complete inhibition of human solid tumors in SCID mice by targeting endothelial cells of tumor vasculature with antihuman endoglin immunotoxin